340 related articles for article (PubMed ID: 25515755)
1. Metabolomics as a tool for drug discovery and personalised medicine. A review.
Mastrangelo A; Armitage EG; García A; Barbas C
Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
Mussap M; Loddo C; Fanni C; Fanos V
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
[No Abstract] [Full Text] [Related]
4. Applications of Metabolomics in Cancer Studies.
Armitage EG; Ciborowski M
Adv Exp Med Biol; 2017; 965():209-234. PubMed ID: 28132182
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics as a Tool to Understand Pathophysiological Processes.
Ivanisevic J; Thomas A
Methods Mol Biol; 2018; 1730():3-28. PubMed ID: 29363062
[TBL] [Abstract][Full Text] [Related]
6. Lipidomics applications for disease biomarker discovery in mammal models.
Zhao YY; Cheng XL; Lin RC; Wei F
Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
Kaddurah-Daouk R; Weinshilboum R;
Clin Pharmacol Ther; 2015 Jul; 98(1):71-5. PubMed ID: 25871646
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics studies in brain tissue: A review.
Gonzalez-Riano C; Garcia A; Barbas C
J Pharm Biomed Anal; 2016 Oct; 130():141-168. PubMed ID: 27451335
[TBL] [Abstract][Full Text] [Related]
9. Emerging applications of metabolomics in drug discovery and precision medicine.
Wishart DS
Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
[TBL] [Abstract][Full Text] [Related]
10. Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment.
Katsila T; Patrinos GP
Curr Pharm Des; 2017; 23(14):2027. PubMed ID: 28701139
[No Abstract] [Full Text] [Related]
11. Human Disease Modelling Techniques: Current Progress.
Glanz VY; Orekhov AN; Deykin AV
Curr Mol Med; 2018; 18(10):655-660. PubMed ID: 30727892
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacometabonomics - the novel way to personalized drug therapy].
Maslov DL; Balashova EE; Lokhov PG; Archakov AI
Biomed Khim; 2017 Mar; 63(2):115-123. PubMed ID: 28414282
[TBL] [Abstract][Full Text] [Related]
13. NMR Metabolomics Protocols for Drug Discovery.
Bhinderwala F; Powers R
Methods Mol Biol; 2019; 2037():265-311. PubMed ID: 31463851
[TBL] [Abstract][Full Text] [Related]
14. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
Everett JR
Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
[TBL] [Abstract][Full Text] [Related]
15. Pharmacometabonomics in humans: a new tool for personalized medicine.
Everett JR
Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
[TBL] [Abstract][Full Text] [Related]
16. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
[TBL] [Abstract][Full Text] [Related]
17. Challenges in metabolomics-based disease molecular classification: an analytical perspective.
Gao Y; Liu Q; Xu F
Bioanalysis; 2017 May; 9(10):771-773. PubMed ID: 28520467
[No Abstract] [Full Text] [Related]
18. Current and future perspectives of functional metabolomics in disease studies-A review.
Yan M; Xu G
Anal Chim Acta; 2018 Dec; 1037():41-54. PubMed ID: 30292314
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
